24/7 eTV BreakingNews Show : Danna maɓallin ƙara (hagu na hagu na allon bidiyo)
Breaking Labaran Duniya Yanke Labaran Balaguro Tafiya Kasuwanci Labaran Gwamnati Rahoton Lafiya Labaran India Labarai Safety Technology Tourism Sabunta Hannun tafiya Labaran Wayar Balaguro Labarai daban -daban

An amince da allurar DNA ta farko ta COVID-19 a Indiya a Indiya

An amince da allurar DNA ta farko ta COVID-19 a Indiya a Indiya
An amince da allurar DNA ta farko ta COVID-19 a Indiya a Indiya
Written by Harry Johnson

Allurar, ZyCoV-D, tana amfani da wani sashi na kayan halitta daga ƙwayar cuta wanda ke ba da umarni kamar DNA ko RNA don yin takamaiman furotin wanda tsarin garkuwar jiki ya gane kuma ya amsa.

Print Friendly, PDF & Email
  • Indiya ta amince da sabon allurar rigakafin cutar coronavirus.
  • An ba da izini don amfani a cikin manya da yara 12 da tsufa.
  • Indiya tana da niyyar yin allurar rigakafin duk manya da suka cancanta kafin Disamba, 2021.

An harbi DNA na farko na duniya akan cutar COVID-19 an ba da izinin amfani da gaggawa ta Hukumar Kula da Magunguna ta Tsakiya ta Gwamnatin Indiya (CDSCO), yayin da har yanzu ƙasar ke ƙoƙarin shawo kan yaduwar cutar a wasu jihohi.

An amince da allurar DNA ta farko ta COVID-19 a Indiya a Indiya

The CDSCO An ba da izini don amfani da gaggawa a cikin manya da yara masu shekaru 12 da haihuwa.

Amincewar za ta ba da harbi na farko ga waɗanda ke ƙasa da shekara 18, kuma za su ba da haɓaka IndiaShirin allurar rigakafin, wanda ke da nufin yin allurar rigakafin duk balagaggun Indiya da suka cancanta zuwa Disamba, 2021.

Allurar, ZyCoV-D, tana amfani da wani sashi na kayan halitta daga ƙwayar cuta wanda ke ba da umarni kamar DNA ko RNA don yin takamaiman furotin wanda tsarin garkuwar jiki ya gane kuma ya amsa.

Ba kamar yawancin alluran rigakafin coronavirus ba, waɗanda ke buƙatar allurai biyu ko ma kashi ɗaya, ana gudanar da ZyCoV-D cikin allurai uku.

Babban mai kera magunguna, wanda aka jera a matsayin Cadila Healthcare Ltd, yana da niyyar yin allurar miliyan 100 zuwa miliyan 120 na ZyCoV-D kowace shekara kuma tuni ya fara tara allurar rigakafin.

Allurar rigakafin Zydus Cadila, wanda aka haɓaka tare da haɗin gwiwar Ma'aikatar Fasaha, shine harbi na biyu na gida don samun izini na gaggawa a Indiya bayan Covaxin na Bharat Biotech.

Mai yin magunguna ya ce a watan Yuli allurar ta COVID-19 ta yi tasiri a kan sabbin kwayoyin cutar coronavirus, musamman bambancin Delta, kuma ana gudanar da harbin ne ta amfani da allurar da babu allura sabanin sirinji na gargajiya.

Kamfanin ya nemi izinin ZyCoV-D a ranar 1 ga Yuli, dangane da ingancin inganci na kashi 66.6 cikin dari a wani gwaji na karshe na sama da masu sa kai 28,000 a duk fadin kasar.

Print Friendly, PDF & Email

Game da marubucin

Harry Johnson

Harry Johnson ya kasance editan aikin eTurboNews na kusan shekaru 20. Yana zaune a Honolulu, Hawaii, kuma asalinsa daga Turai ne. Yana jin daɗin rubutu da ɗaukar labarai.

Leave a Comment